29 ABRIL 2014
Tailoring the Treatment of Locally Advanced Squamous Cell Carcinoma of the Vulva: Neoadjuvant Chemotherapy Followed by Radical Surgery. Results From a Multicenter Study
Alejandro M. Aragona, MD,*† Nicasio Cuneo, MD,* Alejandro
H. Soderini, MD,* Elsa Alcoba, MD,‡ Adriana Greco, MD,§
Carlos Reyes, MD,|| and Silvia Lekmann, MD||
*Department of Gynecologic Oncology, Oncologic Hospital of Buenos
Aires Marie Curie; †University of Buenos Aires (UBA);
‡Division of Anatomic Pathology, Department of Gynecologic
Oncology, Oncologic Hospital of Buenos Aires Marie Curie; §Division
of Gynecology, Parmenio Piñero Hospital; and ||Unit of
Gynecologic Oncology, Division of Gynecology, Parmenio Piñero
Hospital, Buenos Aires, Argentina.
The use of NCH in selected groups may increase surgical
feasibility in initially inoperable patients, thus favoring organ
preservation and less extensive resections. Adverse reactions were
acceptable, and vulvoperineal deleterious effects that may occur
after radiotherapy were consequently avoided.
 Leer...
16 ABRIL 2014
Systemic therapy in squamous cell carcinoma of the vulva: Current status and future directions
Clare J. Reade a,*, Lua R. Eiriksson a,b, Helen Mackay c,d
a Division of Gynecologic Oncology, University of Toronto,
M700-610 University Avenue, Toronto, ON M5N 2L5, Canada
b Division of Gynecologic Oncology, Department of Obstetrics and
Gynecology, Juravinski Cancer Centre, McMaster University, 699
Concession St, Hamilton, ON L8V 5C2, Canada
c Division of Medical Oncology and Hematology, University of
Toronto, Canada
d Princess Margaret Hospital, 610 University Avenue, Toronto, ON
M5G 2M9, Canada
Advances in systemic therapy for vulvar SCC are urgently needed,
especially in the setting of recurrent and metastatic disease. A
focus on the investigation of new targeted agents is encouraged and
consideration of quality of life and sexual health issues is
essential. International cooperation and adaptive trial designs are
required to improve outcomes for this group of traditionally
under-served women.
Leer...
8 ABRIL 2014
An analysis of reported independent prognostic factors for survival in squamous cell carcinoma of the vulva: Is tumor size significance being underrated?
Alejandro M. Aragona a,*, Nicasio A. Cuneo a, Alejandro H.
Soderini a, Elsa B. Alcoba b
a Department of Gynecologic Oncology, Oncology Hospital of Buenos
Aires Marie Curie, Autonomous City of Buenos Aires, Argentina
b Department of Pathology, Oncology Hospital of Buenos Aires Marie
Curie, Autonomous City of Buenos Aires, Argentina
A newhigh-risk groupwas identified based on different cutoff
values for tumor size, extra-nodal growth and number of positive
lymph nodes. This could be very important in the tailored treatment
of a specific group of patients with bulky primary tumors and a
poorer prognosis.
Leer...
15 JULIO 2013
Vídeo: Linfadenectomia lumboaórtica extraperitoneal en cánceres ginecológicos
Saadi, José, Noll Florencia, Perrota Myriam, Orti Roberto,
Gogorza Sebastián
Servicio de Ginecología, sección
ginecología oncológica, Hospital Italiano de Buenos
Aires
Los días 26 y 27 de Abril de 2013 se realizó en la
Academia de Medicina de la Ciudad Autónoma de Buenos Aires el
IX Congreso de la Asociación Argentina de Ginecología
Oncológica en el contexto de “Avances y Controversias en
Ginecología Oncológica”.
En el mismo el jurado integrado por los siguientes ginecólogos
oncólogos ex-presidentes o ex vice-presidentes
Dr Amadeo Aldini
Dra Juana Bayo
Dr Hector Ferreyra
Dr
Alberto Torres
Dra Clelia Vico
Otorgaron el Premio a la presentación de videos al trabajo
“Linfadenectomia lumboaórtica extraperitoneal en
cánceres ginecológicos”.
Leer... |
